Upcoming Webinars

Catch up anytime — previous webinars in this series are available on our on-demand page.

View On-Demand Webinars

Thursday, 22 January 2026 | 7:00 - 8:00 p.m. ET

Microwave ablation has become an essential tool for many interventional oncology practices. Despite the effectiveness and power of the tool, accuracy in placement and margins are still a challenge. Leveraging technology and advanced techniques can improve placement accuracy, consistent margins, and treatment confirmation. In this session, experts in the field will share how they are using technological advancements to improve their procedure in conjunction with the novel IntelliBlate Microwave System.

Faculty

Kirema Garcia-Reyes, MD

Mount Sinai Health

Brian T. Welch, MD

Mayo Clinic

Register Now

This webinar is sponsored by:

Monday, 15 December 2025 | 6:00 – 7:00 p.m. ET

Join us for Training Without Borders: International IR Pathways, a dynamic discussion designed to help U.S. IR trainees understand global training models, navigate logistical considerations for international experiences, and appreciate cultural differences in global IR practice. Featuring Dr. Stephen Hunt and Dr. Fabian Laage Gaupp, and Dr. Takeshi Wada, this session will provide firsthand insights into building meaningful, collaborative IR opportunities abroad. Learning Objectives 1. Understand key differences between U.S. and international IR training pathways and practice environments. 2. Recognize cultural and clinical practice perspectives that shape international IR training and collaboration.

Faculty

 

Jaclyn Lundberg, MD

University of Pennsylvania

 

Stephen Hunt, MD

University of Pennsylvania

 

Fabian Laage Gaupp

Yale University

 

Takeshi Wada, MD

Teikyo University

Register Now

This webinar is sponsored by

Postponed: Stay tuned for more details 

Join us for an engaging webinar titled “Targeting Tumors from Within: Intratumoral Therapies and Team-Based Care in Metastatic Melanoma,” sponsored by Replimune and Johnson & Johnson. This session will explore the evolving treatment landscape for advanced melanoma, with a particular focus on patients who have progressed on PD-1 inhibitors. Attendees will gain valuable insights into second-line treatment strategies, including the role of oncolytic immunotherapies. 

Faculty

Rahul Sheth, MD, FSIR

MD Anderson Cancer Center

Michael Wong, MD, PhD, FRCPC

Roswell Park Comprehensive Cancer Center

This webinar is sponsored by: